227 related articles for article (PubMed ID: 35469784)
21. Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma.
Yan JX; Li QH; Li TZ; Huang ZY; Ma YB; Chen JJ
Drug Dev Res; 2023 Sep; 84(6):1285-1298. PubMed ID: 37345274
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment.
Guo YL; Yu JW; Cao Y; Cheng KX; Dong-Zhi SN; Zhang YF; Ren QJ; Yin Y; Li CL
Eur J Med Chem; 2024 Feb; 265():116061. PubMed ID: 38154256
[TBL] [Abstract][Full Text] [Related]
23. Design, semisynthesis and potent cytotoxic activity of novel 10-fluorocamptothecin derivatives.
Yang CJ; Song ZL; Goto M; Hsu PL; Zhang XS; Yang QR; Liu YQ; Wang MJ; Morris-Natschke SL; Shang XF; Lee KH
Bioorg Med Chem Lett; 2017 Oct; 27(20):4694-4697. PubMed ID: 28927790
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents.
Zi CT; Yang L; Xu FQ; Dong FW; Ma RJ; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM
Bioorg Med Chem Lett; 2019 Jan; 29(2):234-237. PubMed ID: 30509782
[TBL] [Abstract][Full Text] [Related]
25. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of Dual Target CPT-Ala-Nor Conjugates and Their Biological Activity Evaluation.
Zhao CK; Xu L; Wang XH; Bao YJ; Wang Y
Anticancer Agents Med Chem; 2019; 19(4):502-508. PubMed ID: 30663574
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
28. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents.
Li B; Zhu F; He F; Huang Q; Liu X; Wu T; Zhao T; Qiu Y; Wu Z; Xue Y; Fang M
Bioorg Chem; 2020 Mar; 96():103592. PubMed ID: 32044517
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.
Wang MJ; Liu YQ; Chang LC; Wang CY; Zhao YL; Zhao XB; Qian K; Nan X; Yang L; Yang XM; Hung HY; Yang JS; Kuo DH; Goto M; Morris-Natschke SL; Pan SL; Teng CM; Kuo SC; Wu TS; Wu YC; Lee KH
J Med Chem; 2014 Jul; 57(14):6008-18. PubMed ID: 25003995
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro.
Mahavorasirikul W; Viyanant V; Chaijaroenkul W; Itharat A; Na-Bangchang K
BMC Complement Altern Med; 2010 Sep; 10():55. PubMed ID: 20920194
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities.
Guo W; Miao Z; Sheng C; Yao J; Liu W; Zhu L; Zhang Y; Cheng P; Dong G; Zhuang C; Zhang W
Chem Biodivers; 2011 Jul; 8(7):1266-73. PubMed ID: 21766447
[TBL] [Abstract][Full Text] [Related]
33. Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo.
Du H; Huang Y; Hou X; Quan X; Jiang J; Wei X; Liu Y; Li H; Wang P; Zhan M; Ai X; Lu L; Yuan S; Sun L
Eur J Pharm Sci; 2018 Oct; 123():546-559. PubMed ID: 30118848
[TBL] [Abstract][Full Text] [Related]
34. An overview on the development of new potentially active camptothecin analogs against cancer.
Chazin Ede L; Reis Rda R; Junior WT; Moor LF; Vasconcelos TR
Mini Rev Med Chem; 2014; 14(12):953-62. PubMed ID: 25355593
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis of novel chromene-based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c-Src inhibition.
Abdelall EKA; Elshemy HAH; Labib MB; Mohamed FEA
Drug Dev Res; 2024 Feb; 85(1):e22133. PubMed ID: 37971069
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary study of apoptosis of human hepatocarcinoma cell line HepG2 induced by topotecan].
Zhang J; Pu SP; Zhou YJ
Ai Zheng; 2002 Dec; 21(12):1305-9. PubMed ID: 12520736
[TBL] [Abstract][Full Text] [Related]
37. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
[TBL] [Abstract][Full Text] [Related]
39. A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.
Liu Y; Zhang J; Feng S; Zhao T; Li Z; Wang L; Wang P; Du H; Yuan S; Sun L
Anticancer Agents Med Chem; 2019; 19(3):365-374. PubMed ID: 30523769
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]